Grants and Contributions:
Title:
Advancement of a Hypoxia-Activated Reagent for Detection and Mapping of Hypoxia in Cells and Tumors
Agreement Number:
1032297
Agreement Value:
$36,000.00
Agreement Date:
Jul 1, 2025 - Mar 31, 2026
Description:
Firm is developing a product that has therapeutic and diagnostic (theranostic) properties integrated, thus offering a precise, safe and effective solution to both image and treat hypoxic (oxygen deprived) tumors. Firm proposes commercial advancement of one of the lead candidates that offers time & cost-effective precision imaging and quantification of tumor hypoxia, which will help determine an effective therapy plan for patients and offer socioeconomic benefits.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5J 4P6
Reference Number:
172-2025-2026-Q2-1032297
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
776627317
Recipient Type:
For-profit organization
Recipient's Legal Name:
WWiKY BioSciences Inc.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710